Medical research competition
About The UHF Medical Research Competition
The University Hospital Foundation has provided funding and support for the UHF Medical Research Competition (MRC) for more than 20 years. Through MRC, in collaboration with the Faculty of Medicine and Dentistry at the University of Alberta, UHF has funded a broad range of innovative and translational research.
UHF’s new strategic plan, Ignite 2030, challenges us to lead bold solutions to seemingly insurmountable problems and ignite new approaches and discoveries in health. This includes our approach to supporting research excellence, ensuring alignment with our overall strategic direction.
With this in mind, we are pausing the Medical Research Competition in 2022. This pause will allow UHF the opportunity to review its strategy for funding research within Ignite 2030. The review will include collaborative engagement and consultation with key stakeholders and partners. The expected outcome of this process is a renewed approach to funding medical research, better geared toward igniting innovative discoveries and transforming health.
Learn more about the areas that UHF supports.
$4.9 million in research funding from UHFMRC yielded $30.4 million in additional funding
152 research projects were funded and 61% generated at least one peer-reviewed publication
397 researchers have been funded with an average of 15 grants awarded annually
Dr. Ian Winship, Medical Research Competition Awardee
If you want to move closer to a cure for a complex disease like schizophrenia, you need new ideas. The grant from UHF allowed me to take the research in my lab in a whole new direction.
2021 Award Recipients
In 2021, seventeen projects were funded out of a total of 42 submitted for a success rate of 40.5%.
Dr. Mahesh Kate Medicine
Remote Ischemic Conditioning with Novel Optical Sensor Feedback Device in Acute Ischemic Stroke
Dr. Angela Neufeld Anesthesiology & Pain Medicine
Use of Large Volume Autologous Whole Blood Therapy for Treating Cardiopulmonary Bypass-Induced Coagulopathy In High Risk Patients: A Randomized Control Trial
Dr. Sue Tsai Medical Microbiology and Immunology
Oxylipins as novel therapeutics to boost immuno-metabolism of life-saving total parenteral nutrition: a translational study
Dr. Angela Lau Medicine
How much do subclinical patients contribute to tuberculosis transmission?
Dr. Paul Jurasz Pharmacology
Monocyte-Platelet Aggregate Formation in Stroke
Dr. Stephanie Thompson Medicine
Lower limb complications in hemodialysis patients: the feasibility of using non-invasive measurements of vascular function to identify risk and response to treatment
Dr. Thomas Jeerakathil Medicine
Rapid clinical assessment of vertigo using non-invasive eye-tracking and markerless motion-tracking techniques
Dr. Martin Bouliane Surgery
Total versus Reverse Total Shoulder Replacement: A Feasibility Randomized Control Trial
Dr. Rhea Varughese Medicine
REVAMP: Remote Exercise program delivery using A Mobile phone application for patients with Pulmonary hypertension
Dr. Andrew Pepper Surgery
Customized humanized mouse model to advance cell therapies for Type 1 Diabetes
Dr. Darren Lau Medicine
A randomized trial of intermittently scanned CGM versus Usual care with Diabetes Education and feedback, in adults with type 2 diabetes (iCUDE)
Dr. Mahua Ghosh Medicine
Type 2 Diabetes in Women with and without Polycystic Ovary Syndrome: What is the evidence, risk and co-morbidities?
Dr. Kristi Baker Oncology
Activating CD8+ T cell-mediated anti-tumor immunity in colorectal cancer
Dr. Hadi Seikaly Surgery
Engineering Clinically Applicable Cartilage Grafts
Dr. Frank Hoentjen Medicine
Metabolomic profiles to assess colorectal cancer risk in patients with ulcerative colitis
Dr. Carrie Ye Medicine
Opportunistic bone densitometry using computed tomography scan in cancer patients taking immunotherapy: a translational pilot study in oncology
Dr. Karyne Rabey Surgery
Promoting musculoskeletal health with exercise to improve nerve regeneration following peripheral nerve injury
*Statistics on this page are from the 2009-2018 UHFMRC Impact Report